DMP 811
DMP 811 is a potent, orally active and selective angiotensin II subtype receptor AT1 antagonist. DMP 811 exhibits selectivity for AT1 (IC50 = 6 nM) over AT2 (IC50 >10 μM). DMP 811 exhibits potent antihypertensive activity in rats and dogs. DMP 811 can be used for the research of hypertension.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 139964-19-5
- Formule: C23H24N6O2
- Masse moléculaire:416.49
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform Angiotensin Receptor
More
Activité biologique
|
AT1 Receptor 6 nM (IC50) |
AT2 Receptor >10 μM (IC50) |
DMP 811 (0.1 nM-10 μM) selectively binds to AT1 receptors in rat adrenal cortical microsomes with IC50 values of 6 nM (without BSA) and 0.1 μM (with BSA) and shows low affinity for AT2 receptors in rat adrenal medullary membranes (IC50 >10 μM)[1].
DMP 811 (1-100 nM; 15 min) noncompetitively inhibits Ang II (HY-13948)-induced contraction in isolated rabbit aorta[1].
DMP 811 (10 nM; 15 min) completely and selectively inhibits Ang II-induced contraction in guinea pig ileum without affecting responses to acetylcholine, serotonin, or bradykinin[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | AUC | Cmax | Tmax | F | CL | Vss | T1/2 |
|---|---|---|---|---|---|---|---|---|---|
| Rat[1] | 3 mg/kg | i.v. | 40.3 μg·h/mL | 42.2 μg/mL | 0.083 h | / | 0.078 L/h/kg | 0.19 L/kg | 3.0 h |
| Rat[1] | 10 mg/kg | i.v. | 176 μg·h/mL | 154 μg/mL | 0.083 h | / | 0.062 L/h/kg | 0.17 L/kg | 3.7 h |
| Rat[1] | 10 (solution) mg/kg | p.o. | 12.6 μg·h/mL | 1.52 μg/mL | 1.8 h | 7.2 % | / | / | / |
| Rat[1] | 10 (suspension) mg/kg | p.o. | 11.2 μg·h/mL | 1.37 μg/mL | 1.5 h | 6.4 % | / | / | / |
| Rat[1] | 3 (suspension) mg/kg | p.o. | 3.7 μg·h/mL | 0.58 μg/mL | 2.0 h | 9.2 % | / | / | / |
| Dog[1] | 3 mg/kg | i.v. | 15.4 μg·h/mL | / | / | / | 0.20 L/h/kg | 0.38 L/h | 6.6 h |
| Dog[1] | 10 (solution) mg/kg | p.o. | 14.81 μg·h/mL | 4.45 μg/mL | 0.75 h | 29.5 % | / | / | / |
| Dog[1] | 10 (capsule) mg/kg | p.o. | 6.55 μg·h/mL | 0.99 μg/mL | 2.7 h | 13.2 % | / | / | / |
| Dog[1] | 3 (capsule) mg/kg | p.o. | 2.08 μg·h/mL | 0.49 μg/mL | 1.5 h | 13.5 % | / | / | / |
DMP 811 (0.003-0.3 mg/kg; i.g.; single dose) reduces blood pressure in renal hypertensive rats with an oral ED30 of 0.005 mg/kg[1].
DMP 811 (0.3 and 1 mg/kg; i.g.; single dose) reduces blood pressure in Furosemide (HY-B0135)-treated dogs[1].
DMP 811 (0.03-1 mg/kg; i.v.; single dose) inhibits Ang II (HY-13948)-induced pressor responses in pithed rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male CD Sprague-Dawley rats (300-400 g) with renal hypertensive
[1] -
Dosage:0.003-0.1 mg/kg
-
Administration:i.v.; single dose
-
Result:Caused a dose-dependent decrease in blood pressure with an ED30 of 0.005 mg/kg.
-
Animal Model:Male CD Sprague-Dawley rats (300-400 g) with renal hypertensive[1]
-
Dosage:0.03-0.3 mg/kg
-
Administration:p.o.; single dose
-
Result:Caused a dose-dependent decrease in blood pressure with an oral ED30 of 0.03 mg/kg.
-
Animal Model:Mongrel dogs (8-13 kg) treated with Furosemide, and with elevated plasma renin activity)[1]
-
Dosage:0.3, 1 mg/kg
-
Administration:i.g.; single dose
-
Result:Caused a dose-dependent decrease in blood pressure.
Decreased blood pressure by about 30% with a duration greater than 6 h at 1 mg/kg.
-
Animal Model:Male CD Sprague-Dawley rats (300-400 g) pithed normotensive model[1]
-
Dosage:0.03, 0.1, 0.3, 1 mg/kg
-
Administration:i.v.; single dose
-
Result:Shifted the log dose-pressor response curve for Ang II to the right nonparallelly and reduced the maximal Ang II response.
Significantly lowered diastolic blood pressure at 0.03-1 mg/kg.
Did not alter the norepinephrine dose-pressor curve at 1 mg/kg.
Chemical Information
-
CAS No. 139964-19-5
-
Masse moléculaire 416.49
-
Formule C23H24N6O2
-
SMILES
O=C(O)C1=C(N=C(N1CC=2C=CC(=CC2)C=3C=CC=CC3C4=NN=NN4)CCC)CC
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Wong PC, et al. Pharmacology and pharmacokinetics of a novel nonpeptide angiotensin II receptor antagonist--DMP 811. Clin Exp Hypertens. 1995;17(8):1233-1256. [Content Brief]
[3]. Agra AM, et al. High-performance liquid chromatographic determination of a potent AII receptor antagonist (DMP 811) in plasma. J Chromatogr. 1993 Oct 29;620(2):205-9. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
DMP 811 Related Classifications
HY-180401 Related Classifications
Powered by Bioz
- DMP 811
- 139964-19-5
- DMP811
- DMP-811
- Angiotensin Receptor
- angiotensin II subtype receptor AT1
- furosemide-treated dogs
- conscious normotensive CD Sprague-Dawley rats
- guinea pig ileum
- conscious renal hypertensive rats
- rat adrenal medullary membranes
- Mongrel dogs
- isolated rabbit aorta
- CD Sprague-Dawley rats
- AT2
- hypertension
- AT1
- pithed CD Sprague-Dawley rats
- rat adrenal cortical microsomes
- Inhibitor
- inhibitor
- inhibit